This page contains a Flash digital edition of a book.
Clinical Services


Each patient is assigned a Clinical Specialist Nurse, allowing them one- on-one support


|


The Royal Marsden Dr Shelley Dolan joined The Royal Marsden in


1994 as a Clinical Nurse Specialist and in 2000 became the first Nurse Consultant in Cancer: Critical Care in the UK. As Chief Nurse, she has successfully argued for nurses to lead research studies as primary researchers, and there are now 12 PhD- qualified nurses working in the hospital’s health services research unit. Dr Dolan is also Clinical Director for the London Cancer Alliance (LCA). The above are just some examples of the leading


cancer specialists we employ here at The Royal Marsden. We really are making a significant impact on the global effort to making cancer a disease of the past.


Individual nursing support The Royal Marsden is also unique in how we approach nursing. Each of our patients is assigned a Clinical Specialist Nurse, meaning that throughout their journey, they have one-on-one support available whenever they should need it. We have always been at the forefront of quality and research in nursing to ensure patients receive the best care. We know that the treatment pathway for our patients can be lengthy and complex, from public education and awareness to diagnosis, acute treatment and living with and beyond cancer. So we pride ourselves on training nurses to the highest standards so that they can nurture patients through every step of their treatment. We are also leading the way in the nursing


community by engaging closely with our charity partners. For example we have become the first hospital in the UK to employ an Anthony Nolan Clinical Specialist Nurse, specifically caring for leukaemia patients who have just had bone marrow transplants. This is yet another excellent example of how we are always honing our nurses training and expertise in specialist cancer treatment and care and an example of what overseas patients can expect when they arrive at The Royal Marsden.


Unique approach The reputation of the NHS in quality and outcome is also a key reason why we are continuing to see a rapid growth in overseas patients coming to be treated privately at The Royal Marsden, an NHS Foundation Trust. The Royal Marsden is not only a world leading


cancer hospital but is also leading the way in both research and development. The hospital is also unique in its approach to treatment and diagnosis. Every patient treated is discussed in a Multidisciplinary Team Meeting and this approach is continued throughout a patient’s time with The Royal Marsden, meaning that experts from across the hospital are all involved in deciding the best course of treatment for the individual. We are one of the only hospitals to offer such unique treatment of our patients. The hospital is recognised around the world for its expertise in treating all cancer types as well as its research and clinical trials into cancer genetics and targeted therapy. All this expertise is available to overseas patients opting for private treatment with us.


global-opportunity.co.uk Issue 01 | Global Opportunity Healthcare 2015 37


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196  |  Page 197  |  Page 198  |  Page 199  |  Page 200  |  Page 201  |  Page 202  |  Page 203  |  Page 204